BusinessParatek Presents Data from Omadacycline Clinical Development Program at ECCMIDBy Nasdaq OMXApr 11, 2016, 11:30 AM UTC
BusinessParatek Presents Pre-Clinical Data on the Effects of Omadacycline on Clostridium DifficileBy Nasdaq OMXApr 11, 2016, 11:30 AM UTC
BusinessParatek Accelerates Timing for Projected Reporting of Top-Line Data for Omadacycline Phase 3 Skin TrialBy Nasdaq OMXJan 6, 2016, 12:00 PM UTC
